Navigation Links
DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines
Date:11/5/2009

Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC.

Horsham, PA (Vocus) November 5, 2009 -- Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC.

This conference will explore the essential components of RMP as they apply to medicinal products, therapeutic biologics, and vaccines with a focus on real and potential risks of products, which may be made available to patients and healthcare providers in different regions of the world. Sessions will include:

 
  • Risk Management Plans: What Do They Mean and What Are the Requirements for Each Region?
  • Risk Management Plans: What Have We Learned from RMPs About Managing Product Risks?
  • Developing an Harmonized Risk Management Plan
  • Successes and Opportunities for Harmonized Risk Management Plans
  • Risk Management Plans Town Meeting
  • Future Developments of RMPs and REMS
“The 2nd DIA Conference on Harmonization of Risk Management Plans will bring together global regulators and industry representatives to lead hands-on exercises and didactic presentations and to participate in panel discussions,” explains Program Chair William W. Gregory, Director, Safety and Risk Management, Pfizer Inc. “They will discuss why RMPs are important to your organization from a global regulatory perspective, the pros and cons of a global vs. local approach to developing RMPs, how an harmonized RMP can promote efficient, evidence-based decision-making to support the best use of marketed products, and how to develop an harmonized approach to creating an RMP.”

Register for the 2nd DIA Conference on Harmonization of Risk Management Plans.

About the Drug Information Association (DIA):
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3163264.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines
(Date:3/22/2017)... Jose, CA (PRWEB) , ... March 22, 2017 ... ... San Jose, Santa Cruz and Milpitas with a robust, ongoing community enrichment program, ... Housing (FSH), a nonprofit organization which has provided for the critical needs of ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... frustrating and this tool bypasses that. Healthcare facilities across the country are ... to offer their clients and hospitals, across the country, an efficient and quick ...
(Date:3/22/2017)... ... March 22, 2017 , ... Wash Tower Ltd. has released a ... the Wash Tower, the world's first standalone constant pressure bidet. , The videos in ... website at https://www.washtower.com as well as on its social media pages. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the medical ... reports Leslie Norins, MD, PhD. He says investigating this possibility, is important ... virus and in new infections with HIV. , His findings appear on ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... into a research collaboration to translate advances in basic neuroscience at the BMRI ... and beyond. The collaboration seeks to improve movement, vision, and cognition impaired by stroke, ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... NEW YORK , March 22, 2017 /PRNewswire/ ... pharmaceutical industry, Chinese pharmaceutical packaging market size increased ... during 2010-2016. From 2017 to 2021, the market ... 10% and is expected to outnumber RMB140 billion ... two-child policy, the rapid development of biological agents ...
(Date:3/22/2017)... 2017   VWR (NASDAQ: VWR), ... von Produkten und Dienstleistungen für Labors und ... Archives Inc. bekannt, eines internationalen Dienstleisters für ... Zyklus regulierter Forschung, Entwicklung und Vermarktung mit ... Dokumenten und Zusatzdienstleistungen zur Seite steht. EPL ...
(Date:3/22/2017)... 22, 2017  Applied BioMath ( www.appliedbiomath.com ), ... research and development, today announced the latest line-up ... 2017 is a day full of presentations, posters, ... (QSP) community. The focus is to learn about ... accelerating drug research and development. The ...
Breaking Medicine Technology: